{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:13:40Z","timestamp":1790838820628,"version":"4.1.0"},"reference-count":37,"publisher":"American Association for the Advancement of Science (AAAS)","content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Research"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Targeted therapy of Parkinson\u2019s disease is an important challenge because of the blood\u2013brain barrier limitation. Here, we propose a natural killer cell membrane biomimetic nanocomplex (named BLIPO-CUR) delivered via the meningeal lymphatic vessel (MLV) route to further the therapeutic efficacy of Parkinson\u2019s disease. The membrane incorporation enables BLIPO-CUR to target the damaged neurons, thus improving their therapeutic efficacy through clearing reactive oxygen species, suppressing the aggregation of \u03b1-synuclein, and inhibiting the spread of excess \u03b1-synuclein species. Compared with the conventional intravenous injection, this MLV administration can enhance the delivered efficiency of curcumin into the brain by ~20 folds. The MLV route administration of BLIPO-CUR enhances the treatment efficacy of Parkinson\u2019s disease in mouse models by improving their movement disorders and reversing neuron death. Our findings highlight the great potential of MLV route administration used as targeted delivery of drugs to the brain, holding a great promise for neurodegenerative disease therapy.<\/jats:p>","DOI":"10.34133\/research.0030","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T16:43:15Z","timestamp":1673455395000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":50,"title":["Delivery of Biomimetic Liposomes via Meningeal Lymphatic Vessels Route for Targeted Therapy of Parkinson\u2019s Disease"],"prefix":"10.34133","volume":"6","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences, Centre for Cognitive and Brian Sciences, University of Macau, Macau SAR 999078, P. R. China."},{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duyang","family":"Gao","sequence":"additional","affiliation":[{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Hu","sequence":"additional","affiliation":[{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Lan","sequence":"additional","affiliation":[{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yuan","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Centre for Cognitive and Brian Sciences, University of Macau, Macau SAR 999078, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghai","family":"Sheng","sequence":"additional","affiliation":[{"name":"Paul C. Lauterbur Research Center for Biomedical Imaging, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province, Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, CAS Key Laboratory of Health Informatics, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"issue":"1","key":"e_1_3_4_2_2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe W","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag A-E, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017;3(1):Article 17013.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey ER","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384\u2013386.","journal-title":"Neurology"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61393-3"},{"issue":"1","key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2018.2820","article-title":"Patterns of dementia treatment and frank prescribing errors in older adults with Parkinson disease","volume":"76","author":"Mantri S","year":"2019","unstructured":"Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW. Patterns of dementia treatment and frank prescribing errors in older adults with Parkinson disease. JAMA Neurol. 2019;76(1):41\u201349.","journal-title":"JAMA Neurol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.136"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617737728","article-title":"Extended-release oral capsule of carbidopa\u2013levodopa in Parkinson disease","volume":"11","author":"Margolesky J","year":"2018","unstructured":"Margolesky J, Singer C. Extended-release oral capsule of carbidopa\u2013levodopa in Parkinson disease. Ther Adv Neurol Disord. 2018;11:Article 1756285617737728.","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0149-7634(96)00035-8","article-title":"Glutamate antagonists and Parkinson's disease: A review of clinical data","volume":"21","author":"Montastruc JL","year":"1997","unstructured":"Montastruc JL, Rascol O, Senard JM. Glutamate antagonists and Parkinson's disease: A review of clinical data. Neurosci Biobehav Rev. 1997;21(4):477\u2013480.","journal-title":"Neurosci Biobehav Rev"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.01.056"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0205-x"},{"issue":"14","key":"e_1_3_4_11_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101058","article-title":"Enhanced delivery of neuroactive drugs via nasal delivery with a self-healing supramolecular gel","volume":"8","author":"Wang JT-W","year":"2021","unstructured":"Wang JT-W, Rodrigo AC, Patterson AK, Hawkins K, Aly MMS, Sun J, Al Jamal KT, Smith DK. Enhanced delivery of neuroactive drugs via nasal delivery with a self-healing supramolecular gel. Sci Adv. 2021;8(14):Article 2101058.","journal-title":"Sci Adv"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2020.02.033","article-title":"Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease","volume":"321","author":"Oliveira Junior ER","year":"2020","unstructured":"de Oliveira Junior ER, Truzzi E, Ferraro L, Fogagnolo M, Pavan B, Beggiato S, Rustichelli C, Maretti E, Lima EM, Leo E, et al. Nasal administration of nanoencapsulated geraniol\/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease. J Control Release. 2020;321:540\u2013552.","journal-title":"J Control Release"},{"issue":"9","key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy Y","year":"2009","unstructured":"Ozsoy Y, Gungor S, Cevher E. Nasal delivery of high molecular weight drugs. Molecules. 2009;14(9):3754\u20133779.","journal-title":"Molecules"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14432"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0287-8"},{"issue":"1","key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/s41467-020-16851-z","article-title":"Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage","volume":"11","author":"Chen J","year":"2020","unstructured":"Chen J, Wang L, Xu H, Xing L, Zhuang Z, Zheng Y, Li X, Wang C, Chen S, Guo Z, et al. Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage. Nat Commun. 2020;11(1):3159.","journal-title":"Nat Commun"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0368-8"},{"issue":"3","key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","article-title":"Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease","volume":"27","author":"Ding X-B","year":"2021","unstructured":"Ding X-B, Wang X-X, Xia D-H, Liu H, Tian HY, Fu Y, Chen YK, Qin C, Wang JQ, Xiang Z, et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat Med. 2021;27(3):411\u2013418.","journal-title":"Nat Med"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1912-x"},{"key":"e_1_3_4_20_2","article-title":"Glymphatic system and subsidiary pathways drive nanoparticles away from the brain","volume":"2022","author":"Liu R","year":"2022","unstructured":"Liu R, Jia W, Wang Y, Hu C, Yu W, Huang Y, Wang L, Gao H. Glymphatic system and subsidiary pathways drive nanoparticles away from the brain. Research. 2022;2022:Article 9847612.","journal-title":"Research"},{"issue":"7","key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1021\/acs.nanolett.0c01806","article-title":"Therapeutic delivery to the brain via the lymphatic vasculature","volume":"20","author":"Zhao P","year":"2020","unstructured":"Zhao P, Le Z, Liu L, Chen Y. Therapeutic delivery to the brain via the lymphatic vasculature. Nano Lett. 2020;20(7):5415\u20135420.","journal-title":"Nano Lett"},{"issue":"8","key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s12274-020-3280-0","article-title":"Non-invasive delivery of levodopa-loaded nanoparticles to the brain via lymphatic vasculature to enhance treatment of Parkinson\u2019s disease","volume":"14","author":"Nie T","year":"2021","unstructured":"Nie T, He Z, Zhu J, Chen K, Howard GP, Pacheco-Torres J, Minn I, Zhao P, Bhujwalla ZM, Mao HQ, et al. Non-invasive delivery of levodopa-loaded nanoparticles to the brain via lymphatic vasculature to enhance treatment of Parkinson\u2019s disease. Nano Res. 2021;14(8):2749\u20132761.","journal-title":"Nano Res"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.09.005"},{"issue":"7","key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/jf204867v","article-title":"Effects of curcumin concentration and temperature on the spectroscopic properties of liposomal curcumin","volume":"60","author":"Niu Y","year":"2012","unstructured":"Niu Y, Wang X, Chai S, Chen Z, An X, Shen W. Effects of curcumin concentration and temperature on the spectroscopic properties of liposomal curcumin. J Agric Food Chem. 2012;60(7):1865\u20131870.","journal-title":"J Agric Food Chem"},{"issue":"50","key":"e_1_3_4_25_2","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease","volume":"6","author":"Liu L","year":"2020","unstructured":"Liu L, Li Y, Peng H, Liu R, Ji W, Shi Z, Shen J, Ma G, Zhang X. Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease. Sci Adv. 2020;6(50):Article eaba3967.","journal-title":"Sci Adv"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b06453"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2016.07.005"},{"issue":"231","key":"e_1_3_4_28_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007579","article-title":"Immunological visibility: Posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway","volume":"6","author":"Vantourout P","year":"2014","unstructured":"Vantourout P, Willcox C, Turner A, Swanson CM, Haque Y, Sobolev O, Grigoriadis A, Tutt A, Hayday A. Immunological visibility: Posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway. Sci Transl Med. 2014;6(231):Article 231ra49.","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120565"},{"issue":"1","key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s40425-019-0687-9","article-title":"MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a fc-dependent manner","volume":"7","author":"Du C","year":"2019","unstructured":"Du C, Bevers III J, Cook R, Lombana TN, Rajasekaran K, Matsumoto M, Spiess C, Kim JM, Ye Z. MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a fc-dependent manner. J Immunother Cancer. 2019;7(1):207.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee H-J","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ. Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285(12):9262\u20139272.","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","article-title":"Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo","volume":"12","author":"Dutta D","year":"2021","unstructured":"Dutta D, Jana M, Majumder M, Mondal S, Roy A, Pahan K. Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo. Nat Commun. 2021;12(1):5382.","journal-title":"Nat Commun"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbi.2018.02.012","article-title":"Alpha-synuclein oligomers impair memory through glial cell activation and via toll-like receptor 2","volume":"69","author":"La Vitola P","year":"2018","unstructured":"La Vitola P, Balducci C, Cerovic M, Santamaria G, Brandi E, Grandi F, Caldinelli L, Colombo L, Morgese MG, Trabace L, et al. Alpha-synuclein oligomers impair memory through glial cell activation and via toll-like receptor 2. Brain Behav Immun. 2018;69:591\u2013602.","journal-title":"Brain Behav Immun"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1909110117"},{"issue":"1","key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/s41467-020-18113-4","article-title":"Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis","volume":"11","author":"Bolte AC","year":"2020","unstructured":"Bolte AC, Dutta AB, Hurt ME, Smirnov I, Kovacs MA, McKee CA, Ennerfelt HE, Shapiro D, Nguyen BH, Frost EL, et al. Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis. Nat Commun. 2020;11(1):4524.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis V","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc. 2007;2(1):141\u2013151.","journal-title":"Nat Protoc"},{"issue":"9","key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro R","year":"2016","unstructured":"Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S, Yazdi IK, Zhao P, de Rosa E, Sherman MB, et al. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater. 2016;15(9):1037\u20131046.","journal-title":"Nat Mater"},{"issue":"1","key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/acsnano.8b06556","article-title":"Phototheranostics: Active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles","volume":"13","author":"Jia Y","year":"2018","unstructured":"Jia Y, Wang X, Hu D, Wang P, Liu Q, Zhang X, Jiang J, Liu X, Sheng Z, Liu B, et al. Phototheranostics: Active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles. ACS Nano. 2018;13(1):386\u2013398.","journal-title":"ACS Nano"}],"container-title":["Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T23:34:44Z","timestamp":1677540884000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/research.0030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"alternative-id":["10.34133\/research.0030"],"URL":"https:\/\/doi.org\/10.34133\/research.0030","relation":{},"ISSN":["2639-5274"],"issn-type":[{"value":"2639-5274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-09-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0030"}}